These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7682019)

  • 21. [Study of cathepsin D levels in invasive bladder cancer and its stroma. Correlation with tumor stage, cytological grade, lymph node metastasis and survival].
    Carrascosa Lloret C; Cremades Mira A; Sánchez Sanchis M; Rodrigo Guanter V; Beltrán Armada JR; Sala Aznar A; Vacacela Córdova R; Coronel Sánchez B; Clar Blanch F; Tarin Planes M; Sanjuán de Laorden C
    Actas Urol Esp; 2002 May; 26(5):335-8. PubMed ID: 12174741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory).
    Sözen S; Akbal C; Sökmensüer C; Ekici S; Ozen H
    Urol Int; 2002; 69(3):200-6. PubMed ID: 12372888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3).
    Bongiovanni L; Arena V; Vecchio FM; Racioppi M; Bassi P; Pierconti F
    Arch Ital Urol Androl; 2013 Jun; 85(2):73-7. PubMed ID: 23820653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basement membranes in urothelial carcinoma.
    Conn IG; Crocker J; Wallace DM; Hughes MA; Hilton CJ
    Br J Urol; 1987 Dec; 60(6):536-42. PubMed ID: 3427340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of the laminin immunohistochemical stain in distinguishing invasive from noninvasive urothelial carcinoma.
    Pradhan D; Amin M; Hooda S; Dhir R; Bastacky S; Parwani AV
    J Cancer Res Ther; 2017; 13(6):947-950. PubMed ID: 29237956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E-cadherin tissue expression and urinary soluble forms of E-cadherin in patients with bladder transitional cell carcinoma.
    Shi B; Laudon V; Yu S; Dong D; Zhu Y; Xu Z
    Urol Int; 2008; 81(3):320-4. PubMed ID: 18931551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of Ki-67 labeling in predicting the recurrence and progression of superficial bladder transitional cell carcinoma.
    Blanchet P; Droupy S; Eschwege P; Viellefond A; Paradis V; Pichon MF; Jardin A; Benoit G
    Eur Urol; 2001 Aug; 40(2):169-75. PubMed ID: 11528194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma.
    Tsui KH; Cheng AJ; Chang Pe; Pan TL; Yung BY
    Urology; 2004 Oct; 64(4):839-44. PubMed ID: 15491744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of serum laminin P1 in the diagnosis of transitional cell carcinoma of the bladder.
    Abou Farha KM; Menheere PP; Bruins JL; Kester AD; Janknegt R
    Eur Urol; 1992; 21(3):240-4. PubMed ID: 1499633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
    Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
    Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease.
    Margulis V; Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    Clin Cancer Res; 2006 Dec; 12(24):7369-73. PubMed ID: 17189409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of random biopsies of healthy mucosa in superficial bladder tumor].
    Fernández Gómez JM; Rodríguez Martínez JJ; Escaf Barmadah S; Pérez García J; García J; Casasola Chamorro J
    Arch Esp Urol; 2000 Nov; 53(9):785-97. PubMed ID: 11196385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase activity in patients with transitional cell carcinoma: a preliminary study.
    Rahat MA; Lahat N; Gazawi H; Resnick MB; Sova Y; Ben-Ari G; Cohen M; Stein A
    Cancer; 1999 Feb; 85(4):919-24. PubMed ID: 10091771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translational studies of glutathione in bladder cancer cell lines and human specimens.
    Pendyala L; Velagapudi S; Toth K; Zdanowicz J; Glaves D; Slocum H; Perez R; Huben R; Creaven PJ; Raghavan D
    Clin Cancer Res; 1997 May; 3(5):793-8. PubMed ID: 9815751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
    May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
    Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of thymidine phosphorylase is a prognostic predictor for the intravesical recurrence of superficial bladder cancer.
    Nonomura N; Nakai Y; Nakayama M; Inoue H; Nishimura K; Hatanaka E; Arima R; Kishimoto T; Miki T; Kuroda H; Okuyama A
    Int J Clin Oncol; 2006 Aug; 11(4):297-302. PubMed ID: 16937303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.